RE:RE:RE:Just hopeAgreed, there was absolutely nothing in that email that wasn't already known via previous news releases or reasonably good common sense or knowledge of where they are at in the clinical trial, or in SOME of the many various ways that they either have, are trying to, or would like to raise additional capital. The email was merely a concise (and perhaps rather timely) reminder of these things, sent to those folk interested enough in the company to have asked to be put on a mailing list!